Genetic Testing Services Market
Global Genetic Testing Services Market Size, Share & Trends Analysis Report by Type (Allogeneic and Autologous), By Application (Research and Therapeutics) and Forecast 2019-2025 Update Available - Forecast 2024-2030
The global Genetic Testing Services market is projected to have a considerable CAGR during the forecast period. The market growth mainly backed by the growing various chronic and infectious diseases such as cancer, infectious disease and others across the globe. The genetic alterations enable in driving development & progress of different types of cancer which are identified through the platform of research studies. Genomic studies and advanced technologies enable defining driver mutation and alteration of DNA & RNA in many cancers. The genomic information from tumors and normal tissue are compared which helps the required genomic changes. Moreover, government investments in genomic research and technological development gene testing further provide substantial opportunities to the market.
Segmental Outlook
The global genetic testing services market is segmented on the basis of type and application. Based on the type, the market is further classified into predictive & presymptomatic testing, prenatal testing, diagnostic testing, newborn screening, and others (pharmacogenomic testing). The predictive & presymptomatic testing segment is projected to have considerable growth owing to the growing application in testing in various diseases such as cancer, infectious disease, and others. Based on the application, the global genetic testing services market is further segmented into oncology, infectious diseases, autoimmune disease, and others (rare disease).
Global Genetic Testing Services Market Share by Application, 2018(%)
Global Genetic Testing Services Market to be driven by Oncology Application
The oncology segment held a considerable share in the market owing to the growing application of genetic testing in various cancer types coupled with the increasing prevalence of cancer across the globe. As per the International Agency for Research on Cancer (IARC), in 2018 there were 17 million new cancer cases and 9.5 million cancer mortality across the globe. Moreover, the global cancer burden is expected to grow to 27.5 million new cancer cases and 16.3 million cancer mortality in 2020. The genomic methods are used to detect molecular characteristics for clinical phenotypes which enables the detection of genetic changes. Various cancer screening and early detection tools and techniques are being developed such as the “liquid biopsy" a non-invasive technology that provides identification of genetic material presence from cancer cells in blood or molecular markers in urine, saliva which identify precursor lesions or cancer at an early stage.
Regional Outlook
Geographically, the global Genetic Testing Services market is further classified into North America, Europe, Asia-Pacific and the Rest of the World. Asia-Pacific is estimated to have considerable market growth in the global market during the forecast period. The market growth in the region is increasing owing to the high prevalence of different types of cancer coupled with growing awareness in emerging economies. The major countries which will have a significant market share during the forecast period are India, China, and Japan. Apart from these nations, South Korea and Singapore are some of the other major economies where considerable growth would be observed.
Global Genetic Testing Services Market Growth, by Region 2019-2025
North America to hold a considerable share in the global Genetic Testing Services market
Geographically, North America is projected to hold a significant market share in the global genetic testing services market. Major economies which are anticipated to contribute to the North America genetic testing market are the US and Canada. Moreover, the rising number of cancer patients is considered to be one of the major factors that are driving the growth of the market in the North America region. According to the American Cancer Society for 2017, a number of 1.6 million new cancer cases were diagnosed and 600,920 people die due to cancer in the US. Additionally, NIH has estimated that there will be 1,735,350 new cases of cancer in the US by the end of 2018. The government and private sector of the US is investing in the R&D for the healthcare sector is driving the market of the US. As the investment in research and development increases in the US, the opportunities for the development of advanced testing such as genetic testing services are expected to increase significantly.
Market Players Outlook
The key players in the Genetic Testing Services market contributing significantly by providing different types of products and increasing their geographical presence across the globe. The key players of the market include Abbott Laboratories, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Danaher Corp., Illumina, Inc., and others. These market players adopt various strategies such as product launch, partnerships, collaborations, mergers, and acquisitions to sustain a strong position in the market.
The Report Covers
- Market value data analysis of 2018 and forecast to 2025.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global Genetic Testing Services market. Based on the availability of data, information related to products & services, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Abbott Laboratories
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Bio-Rad Laboratories, Inc.
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. Danaher Corp.
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. F. Hoffmann-La Roche Ltd.
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. Illumina, Inc.
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Genetic Testing Services Market by Type
5.1.1. Predictive & Presymptomatic Testing
5.1.2. Prenatal Testing
5.1.3. Diagnostic Testing
5.1.4. Newborn Screening
5.1.5. Others (pharmacogenomic testing)
5.2. Global Genetic Testing Services Market by Application
5.2.1. Oncology
5.2.2. Infectious Diseases
5.2.3. Autoimmune Disease
5.2.4. Others (Rare Disease)
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. 23andMe, Inc.
7.2. Abbott Laboratories
7.3. Ambry Genetics Corp, A Konica Minolta Company
7.4. Blueprint Genetics Oy
7.5. bioMérieux SA
7.6. BGI Genomics Co., Ltd.
7.7. Bio-Rad Laboratories, Inc.
7.8. deCODE genetics
7.9. Danaher Corp.
7.10. Centogene AG
7.11. Eurofins GSC Lux SARL
7.12. F. Hoffmann-La Roche Ltd.
7.13. GeneDx, Inc.
7.14. Helix OpCo LLC
7.15. Illumina, Inc.
7.16. Luminex Corp.
7.17. Myriad Genetics, Inc.
7.18. NeoGenomics Laboratories, Inc.
7.19. PerkinElmer Inc.
7.20. Quest Diagnostics Inc.
1. GLOBAL GENETIC TESTING SERVICES MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
2. GLOBAL PREDICTIVE & PRESYMPTOMATIC TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
3. GLOBAL PRENATAL TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
4. GLOBAL DIAGNOSTIC TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
5. GLOBAL NEWBORN SCREENING MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
6. GLOBAL OTHERS GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
7. GLOBAL GENETIC TESTING SERVICES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
8. GLOBAL GENETIC TESTING SERVICES IN ONCOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
9. GLOBAL GENETIC TESTING SERVICES IN INFECTIOUS DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
10. GLOBAL GENETIC TESTING SERVICES IN AUTOIMMUNE DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
11. GLOBAL GENETIC TESTING SERVICES IN OTHER APPLICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
12. GLOBAL GENETIC TESTING SERVICES MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
13. NORTH AMERICAN GENETIC TESTING SERVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
14. NORTH AMERICAN GENETIC TESTING SERVICES MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
15. NORTH AMERICAN GENETIC TESTING SERVICES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
16. EUROPEAN GENETIC TESTING SERVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
17. EUROPEAN GENETIC TESTING SERVICES MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
18. EUROPEAN GENETIC TESTING SERVICES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
19. ASIA-PACIFIC GENETIC TESTING SERVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
20. ASIA-PACIFIC GENETIC TESTING SERVICES MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
21. ASIA-PACIFIC GENETIC TESTING SERVICES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
22. REST OF THE WORLD GENETIC TESTING SERVICES MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
23. REST OF THE WORLD GENETIC TESTING SERVICES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
1. GLOBAL GENETIC TESTING SERVICES MARKET SHARE BY TYPE, 2018 VS 2025 (%)
2. GLOBAL GENETIC TESTING SERVICES MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)
3. GLOBAL GENETIC TESTING SERVICES MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
4. US GENETIC TESTING SERVICES MARKET SIZE, 2018-2025 ($ MILLION)
5. CANADA GENETIC TESTING SERVICES MARKET SIZE, 2018-2025 ($ MILLION)
6. UK GENETIC TESTING SERVICES MARKET SIZE, 2018-2025 ($ MILLION)
7. FRANCE GENETIC TESTING SERVICES MARKET SIZE, 2018-2025 ($ MILLION)
8. GERMANY GENETIC TESTING SERVICES MARKET SIZE, 2018-2025 ($ MILLION)
9. ITALY GENETIC TESTING SERVICES MARKET SIZE, 2018-2025 ($ MILLION)
10. SPAIN GENETIC TESTING SERVICES MARKET SIZE, 2018-2025 ($ MILLION)
11. ROE GENETIC TESTING SERVICES MARKET SIZE, 2018-2025 ($ MILLION)
12. INDIA GENETIC TESTING SERVICES MARKET SIZE, 2018-2025 ($ MILLION)
13. CHINA GENETIC TESTING SERVICES MARKET SIZE, 2018-2025 ($ MILLION)
14. JAPAN GENETIC TESTING SERVICES MARKET SIZE, 2018-2025 ($ MILLION)
15. REST OF ASIA-PACIFIC GENETIC TESTING SERVICES MARKET SIZE, 2018-2025 ($ MILLION)
16. REST OF THE WORLD GENETIC TESTING SERVICES MARKET SIZE, 2018-2025 ($ MILLION)
